University of Nottingham

Vivani Medical Appoints Daniel Bradbury to its Board of Directors

Retrieved on: 
Wednesday, March 6, 2024

Vivani Medical, Inc. (Nasdaq: VANI ) (“Vivani” or the “Company”), an innovative, preclinical-stage biopharmaceutical company developing novel, long-term drug implants, today announced the appointment of long-time industry veteran Daniel Bradbury to its Board of Directors.

Key Points: 
  • Vivani Medical, Inc. (Nasdaq: VANI ) (“Vivani” or the “Company”), an innovative, preclinical-stage biopharmaceutical company developing novel, long-term drug implants, today announced the appointment of long-time industry veteran Daniel Bradbury to its Board of Directors.
  • Bradbury serves on the board of directors of Castle Biosciences, Inc. and Equillium, Inc., and several private companies and philanthropic organizations.
  • Bradbury previously served on the board of directors of Biocon Limited, Corcept Therapeutics Inc., Geron Inc., Illumina Inc. and Intercept Pharmaceuticals Inc.
  • In addition to his new role as Board Director, Bradbury will serve on the Audit Committee of the Vivani Medical Board.

PomeGran Appoints New CEO and CFO to Execute Strategic Scaling Initiatives as Canada’s Leading Fibre-centric Rural Broadband Provider Expands

Retrieved on: 
Thursday, February 22, 2024

PomeGran Inc. , Canada’s leading fibre-centric rural broadband provider, announced today the appointment of two telecom veterans to the C-suite, to add executive leadership strength and increase the company’s focus on strategic scaling initiatives for its hyper-expansion across rural Canada and the US.

Key Points: 
  • PomeGran Inc. , Canada’s leading fibre-centric rural broadband provider, announced today the appointment of two telecom veterans to the C-suite, to add executive leadership strength and increase the company’s focus on strategic scaling initiatives for its hyper-expansion across rural Canada and the US.
  • PomeGran has appointed Brent Johnston as CEO and Kurban Khanbhai as CFO, both effective immediately.
  • Johnston is a seasoned telecom executive, with his most recent tenure as President of Rogers Wireless.
  • Over the next six months, Brent and Kurban will be supporting PomeGran’s expansion strategies, including additional acquisitions and broadband network expansion projects.

NIO Inc. Announces Board Change

Retrieved on: 
Wednesday, February 7, 2024

SHANGHAI, China, Feb. 07, 2024 (GLOBE NEWSWIRE) -- (NYSE: NIO; HKEX: 9866; SGX: NIO) (“NIO” or the “Company”), a pioneer and a leading company in the premium smart electric vehicle market, today announced that Mr. Eddy Georges Skaf and Mr. Nicholas Paul Collins have been appointed as new directors by the Company’s board of directors (the “Board”), with effect from February 7, 2024.

Key Points: 
  • SHANGHAI, China, Feb. 07, 2024 (GLOBE NEWSWIRE) -- (NYSE: NIO; HKEX: 9866; SGX: NIO) (“NIO” or the “Company”), a pioneer and a leading company in the premium smart electric vehicle market, today announced that Mr. Eddy Georges Skaf and Mr. Nicholas Paul Collins have been appointed as new directors by the Company’s board of directors (the “Board”), with effect from February 7, 2024.
  • Mr. Eddy Georges Skaf has held the position of chief investment officer at CYVN Holdings L.L.C since May 2023.
  • Previously, from August 2019 to May 2023, Mr. Skaf served as a senior advisor to Digital Infrastructure at Mubadala.
  • The Company would like to welcome Mr. Eddy Georges Skaf and Mr. Nicholas Paul Collins to the Board.

EnteroBiotix Strengthens its Executive Team, Appoints COO and CFO

Retrieved on: 
Thursday, February 1, 2024

Dr Barnes has eighteen years’ early and late phase drug development and business operations leadership experience, spanning several therapeutic areas.

Key Points: 
  • Dr Barnes has eighteen years’ early and late phase drug development and business operations leadership experience, spanning several therapeutic areas.
  • He joins the Company from BerGenBio, a biotech company developing innovative drugs for oncology and serious respiratory infections, where he was COO.
  • Dr Barnes previously worked at Vertex Pharmaceuticals as Director of Regulatory Affairs where he led the strategy development of several breakthrough products.
  • With our first clinical data expected this year, the newly strengthened Executive Team will support the development and growth of our business.

A Powerful Alliance: Dexcom G7 Now Connects to Tandem t:slim X2

Retrieved on: 
Monday, January 15, 2024

DexCom, Inc. (Nasdaq: DXCM), a global leader in real-time continuous glucose monitoring for people with diabetes, announced today the Dexcom G7 Continuous Glucose Monitoring (CGM) System now connects with the t:slim X2™ insulin pump by Tandem Diabetes Care in countries across Europe and in South Africa.

Key Points: 
  • DexCom, Inc. (Nasdaq: DXCM), a global leader in real-time continuous glucose monitoring for people with diabetes, announced today the Dexcom G7 Continuous Glucose Monitoring (CGM) System now connects with the t:slim X2™ insulin pump by Tandem Diabetes Care in countries across Europe and in South Africa.
  • The announcement comes just a month after the system launched in the United States and combines the power and accuracy of Dexcom G7 with the discretion of the Tandem t:slim X2.
  • Additionally, the COMISAIR seven-year follow up demonstrated further substantial reduction in HbA1c when Dexcom CGM is connected to the t:slim X2 insulin pump with Control-IQ technology5.
  • To learn more and to get started with Dexcom G7 and the Tandem t:slim X2 insulin pump, visit Dexcom.co.uk/tandem.

Wugen to Present New Clinical Data for WU-CART-007 and Preclinical Data for WU-NK-101, Two Investigational Allogeneic Cell Therapies for Challenging Hematologic Cancers, at American Society of Hematology Annual Meeting & Exposition

Retrieved on: 
Thursday, November 2, 2023

ST. LOUIS and SAN DIEGO, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Wugen, Inc., a clinical-stage biotechnology company developing allogeneic, off-the-shelf cell therapies for the treatment of hematological and solid tumor malignancies, will be presenting four abstracts, now available online, at the American Society of Hematology (ASH) Annual Meeting and Exposition Dec. 9-12.

Key Points: 
  • The Wugen oral and poster presentation schedule at ASH is below.
  • The meeting will take place at the Marriott Marquis in San Diego and virtually.
  • Access the full schedule here .
  • Session: #704, Cellular Immunotherapies: Early Phase and Investigational Therapies: Novel Approaches to Enhance Cellular Therapies and Immune Responses in Leukemias and Lymphomas, 10:30 a.m.- 12 p.m. PT
    Session: #703, Cellular Immunotherapies: Basic and Translational: Novel Approaches for Next Generation Cellular Immunotherapies, 9:30-11 a.m. PT

Macomics Announces the Appointment of Kevin Lee as Independent Non-Executive Director

Retrieved on: 
Thursday, October 19, 2023

EDINBURGH and CAMBRIDGE, United Kingdom, Oct. 19, 2023 (GLOBE NEWSWIRE) -- Macomics Ltd, a leader in macrophage drug discovery, announces that it has appointed Kevin Lee Ph.D., MBA as Independent Non-Executive Director.

Key Points: 
  • EDINBURGH and CAMBRIDGE, United Kingdom, Oct. 19, 2023 (GLOBE NEWSWIRE) -- Macomics Ltd, a leader in macrophage drug discovery, announces that it has appointed Kevin Lee Ph.D., MBA as Independent Non-Executive Director.
  • Based in the UK and CEO of Cambridge, UK/Cambridge, US based, Bicycle Therapeutics (NASDAQ: BCYC), Kevin brings two decades of biotech and pharma experience to Macomics.
  • He joined Bicycle from Pfizer, where he served as senior vice president and CSO of the Rare Disease Research Unit.
  • I look forward to work closely with Kevin to bring next generation macrophage targeting therapeutics to cancer patients.”

Persephone Biosciences Appoints Daniel Bradbury as Chair of the Board of Directors

Retrieved on: 
Monday, October 23, 2023

Persephone Biosciences Inc., a biotechnology company reimagining patient health through the development of microbiome-based medicines, today announced that it has appointed Daniel Bradbury as Chair of the Board of Directors.

Key Points: 
  • Persephone Biosciences Inc., a biotechnology company reimagining patient health through the development of microbiome-based medicines, today announced that it has appointed Daniel Bradbury as Chair of the Board of Directors.
  • Additionally, Persephone has a further two clinical studies underway, namely our ARGONAUT study of gut microbiome-linked immune modulation in cancer treatment response, and our AMBROSIA food-as-medicine study.
  • “As Chair, Dan brings his vast experience as a serial entrepreneur, spanning both public and private biotechs, to our company.
  • In addition, Mr. Bradbury serves on the Keck Graduate Institute’s Board of Trustees and the University of California San Diego’s Rady School of Management Dean’s Advisory Council.

Register Now for the 4th International Conference on Innovative Intelligent Industrial Production and Logistics (Rome, Italy - November 15-17, 2023) - ResearchAndMarkets.com

Retrieved on: 
Thursday, October 12, 2023

El-Houssaine Aghezzaf, Ghent University, Faculty of Engineering and Architecture, Belgium

Key Points: 
  • El-Houssaine Aghezzaf, Ghent University, Faculty of Engineering and Architecture, Belgium
    Nouha Baccour, National Engineering School of Sfax of the University of Sfax, Tunisia
    Patrick Brandtner, University of Applied Sciences Steyr, Austria
    Hing Kai Chan, University of Nottingham Ningbo China, China
    Xavier Delorme, Ecole Nationale Superieure des Mines de Saint-Etienne, France
    Mikael Gidlund, Department of Information Systems and Technology (IST), Mid Sweden University, Sweden
    Manuel Gilberto Gilberto Santos, Polytechnic Institute of Cavado and Ave, Portugal
    Virginie Goepp, Institut National des Sciences Appliquees de Strasbourg, France
    Zivana Jakovljevic, University of Belgrade - Faculty of Mechanical Engineering, Serbia
    Arkadiusz Kawa, Institute of Logistics and Warehousing, Poland
    Manas Khatua, Indian Institute of Technology Guwahati, India
    Andre Andrade Longaray, Federal Foundation University of Rio Grande, Brazil
    Sergio Martin, UNED - Spanish University for Distance Education, Spain
    Rafal Michalski, Wroclaw University of Science and Technology, Poland
    Christian Neureiter, Salzburg University of Applied Sciences, Austria
    Yaodong Ni, University of International Business and Economics, China
    Anthony M. M. Pagano, University of Illinois at Chicago, United States
    Vikram Sharma, The LNM Institute of Information Technology, India
    Neeraj Kumar Singh, National School Electrical Electronics Computer Hydraulics Telecommunications, France

Register Now for the 4th International Conference on Innovative Intelligent Industrial Production and Logistics (Rome, Italy - November 15-17, 2023)

Retrieved on: 
Saturday, October 7, 2023

El-Houssaine Aghezzaf, Ghent University, Faculty of Engineering and Architecture, Belgium

Key Points: 
  • El-Houssaine Aghezzaf, Ghent University, Faculty of Engineering and Architecture, Belgium
    Nouha Baccour, National Engineering School of Sfax of the University of Sfax, Tunisia
    Patrick Brandtner, University of Applied Sciences Steyr, Austria
    Hing Kai Chan, University of Nottingham Ningbo China, China
    Xavier Delorme, Ecole Nationale Superieure des Mines de Saint-Etienne, France
    Mikael Gidlund, Department of Information Systems and Technology (IST), Mid Sweden University, Sweden
    Manuel Gilberto Gilberto Santos, Polytechnic Institute of Cavado and Ave, Portugal
    Virginie Goepp, Institut National des Sciences Appliquees de Strasbourg, France
    Zivana Jakovljevic, University of Belgrade - Faculty of Mechanical Engineering, Serbia
    Arkadiusz Kawa, Institute of Logistics and Warehousing, Poland
    Manas Khatua, Indian Institute of Technology Guwahati, India
    Andre Andrade Longaray, Federal Foundation University of Rio Grande, Brazil
    Sergio Martin, UNED - Spanish University for Distance Education, Spain
    Rafal Michalski, Wroclaw University of Science and Technology, Poland
    Christian Neureiter, Salzburg University of Applied Sciences, Austria
    Yaodong Ni, University of International Business and Economics, China
    Anthony M. M. Pagano, University of Illinois at Chicago, United States
    Vikram Sharma, The LNM Institute of Information Technology, India
    Neeraj Kumar Singh, National School Electrical Electronics Computer Hydraulics Telecommunications, France